Evidence map›Paper›PMID 29614819›Full record

ReviewInternational journal of molecular sciences2018

Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer.

Deok-Hoon Kong, Young Kwan Kim, Mi Ra Kim, Ji Hye Jang, Sukmook Lee

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 393 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
393citing papers in PubMed, 6 pooled it
27.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

393 citing papers in PubMed, 6 syntheses or guidelines pooled it, 672 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. A systematic review and meta-analysis of circulating adhesion molecules in rheumatoid arthritis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Evaluation of ICAM and VCAM as biomarkers in serum and bronchoscopic lavage samples of lung cancer patients.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  16. Article
  17. Immunity in Rodent Models of Stress.Biological psychiatry · 2026
    Review
  18. Article
  19. Article
  20. Review

333 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Deok-Hoon KongResearch Center, Scripps Korea Antibody Institute, Chuncheon 200-701, Korea. kong0131@skai.or.kr.
Young Kwan KimResearch Center, Scripps Korea Antibody Institute, Chuncheon 200-701, Korea. youngk@skai.or.kr.
Mi Ra KimResearch Center, Scripps Korea Antibody Institute, Chuncheon 200-701, Korea. cslove526@skai.or.kr.
Ji Hye JangResearch Center, Scripps Korea Antibody Institute, Chuncheon 200-701, Korea. jjh717@skai.or.kr.
Sukmook LeeResearch Center, Scripps Korea Antibody Institute, Chuncheon 200-701, Korea. Lees@skai.or.kr.
Scripps Korea Antibody Institute · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor necrosis factor alpha (TNFα) is a pro-inflammatory cytokine that triggers the expression of inflammatory molecules, including other cytokines and cell adhesion molecules. TNFα induces the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 (VCAM-1). VCAM-1 was originally identified as a cell adhesion molecule that helps regulate inflammation-associated vascular adhesion and the transendothelial migration of leukocytes, such as macrophages and T cells. Recent evidence suggests that VCAM-1 is closely associated with the progression of various immunological disorders, including rheumatoid arthritis, asthma, transplant rejection, and cancer. This review covers the role and relevance of VCAM-1 in inflammation, and also highlights the emerging potential of VCAM-1 as a novel therapeutic target in immunological disorders and cancer.

Indexed as

AnimalsHumansInflammationNeoplasmsTumor Necrosis Factor-alphaVascular Cell Adhesion Molecule-1Tumor Necrosis Factor-alphaVascular Cell Adhesion Molecule-1antibodycancerimmunological disorderinflammationtherapeutic targettumor necrosis factor αvascular cell adhesion molecule-1

Identifiers

PMID29614819
PMCPMC5979609
OpenAlexW2794944537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.